Fortrea Holdings FTRE
NASDAQ FTRE
$18.16 -0.46 (-2.47%)
As of: Sep 4, 2026 · 1:30 PM EDT

Fortrea Holdings (FTRE) Asset Writedowns and Impairment (2023 - 2026)

Fortrea Holdings' (FTRE) quarterly Asset Writedowns and Impairment came in at $1.0 million in Q2 2026, down 99.68% YoY from $309.1 million in Q2 2025, and down 66.67% on a QoQ basis from $3.0 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 4 years of Asset Writedowns and Impairment data on file, last reported at $1.0 million in Q2 2026.

  • Quarterly Asset Writedowns and Impairment fell 99.68% year-over-year to $1.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.0 million (down 99.5% YoY) and the FY2025 annual result came in at $797.9 million, up 3224.58% from the prior year.
  • Asset Writedowns and Impairment retreated to $1.0 million in Q2 2026, from $3.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $488.8 million in Q1 2025 to a low of $1.0 million in Q2 2026.
  • A 4-year average of $108.2 million and a median of $17.0 million in 2023 frame the typical range for Asset Writedowns and Impairment.
  • Annual changes were most pronounced in 2025 — Asset Writedowns and Impairment jumped 2433.61% — and 2026, when it plunged 99.68%.
  • Tracing FTRE's Asset Writedowns and Impairment over 4 years: stood at $5.9 million in 2023, then surged by 106.78% to $12.2 million in 2024, then jumped by 2433.61% to $309.1 million in 2025, then sank by 99.68% to $1.0 million in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $1.0 million (Q2 2026), $3.0 million (Q1 2026), and $309.1 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 3.00 Mn
Jun 30, 2025 309.10 Mn
Mar 31, 2025 488.80 Mn
Jun 30, 2024 12.20 Mn
Mar 31, 2024 24.00 Mn
Dec 31, 2023 5.90 Mn
Sep 30, 2023 21.90 Mn